Providence Medical Technology announces new equity financing of $10.5 million
Providence Medical Technology, Inc., an innovator in tissue-sparing, cervical-fusion technology, has announced the closing of $10.5 million in new equity financing for the company.
Wilson Therapeutics announces that WTX101 meets the primary endpoint in Phase 2 study in Wilson Disease
Wilson Therapeutics AB has announced that the Phase II study of WTX101 (bis-choline tetrathiomolybdate; Decuperate®), an investigational first in class copper modulating agent with a unique mode of action for the treatment of patients with Wilson Disease, met its primary endpoint.
MVM invests €15.2m in Valneva SE
Valneva SE is a commercial stage vaccine company with products to prevent Japanese encephalitis and cholera
MVM Life Science Partners LLP closes MVM IV
MVM Life Science Partners LLP announces the closing of a $233 million healthcare fund, MVM IV.
Heptares and Allergan Announce Global R&D and Commercialization Partnership
Heptares and Allergan Announce Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer's and Other Neurological Disorders
bioTheranostics Raises $32 Million in a Private Equity Financing & Announces Spinout From bioMérieux
bioTheranostics, Inc., a leader in molecular diagnostics for cancer, has announced that it has closed a $32 million financing led by MVM Life Science Partners.